Events Archives - Page 76 of 128

1 minute read

ProSomnus Announces Publication Of Four Accepted Abstracts In The Journal Of Dental Sleep Medicine In Advance Of Annual Meeting

April 18, 8:23 AM

ProSomnus, Inc. ("the Company") (NASDAQ:OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced the publication of four abstracts in

OSA

2 minute read

Precision BioSciences Announces Late-Breaking Abstract Of Preclinical In Vivo Gene Editing Research Selected For Oral Presentation At The American Society Of Gene & Cell Therapy 26th Annual Meeting

By Happy Mohamed

April 18, 8:20 AM

- Presentation to Highlight Preclinical Development Progress of PBGENE-DMD Program for Potential Treatment of Duchenne Muscular Dystrophy Precision BioSciences, Inc. (NASDAQ:DTIL), a clinical stage gene editing

DTIL

2 minute read

Adverum Biotechnologies Announces Upcoming Nonclinical Data Presentation Supporting Staggered Bilateral Administration Of Ixoberogene Soroparvovec At The 2023 ARVO Annual Meeting

By Happy Mohamed

April 17, 4:07 PM

Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that the company will present an

ADVM

2 minute read

GRAIL A Subsidiary Of Illumina And AstraZeneca Present New Data Demonstrating That Methylation Assay Detects Residual Hematologic Cancer After Treatment At AACR 2023

By Happy Mohamed

April 17, 4:06 PM

GRAIL's Methylation Assay Had 92% Cancer Detection Rate Across Six Hematologic Malignancies With 96% Accuracy in Determining the Hematologic Malignancy Subtype Findings Support Use of GRAIL's

AZN

2 minute read

EXCLUSIVE: Funding Alternatives For Cannabis Companies Present Unique Opportunities For Investors

By Joana Scopel

April 17, 3:37 PM

The cannabis industry has been affected by disruptions in the banking industry and changes in funding sources.

GTBIF

4 minute read

MapKure, BeiGene And SpringWorks Present Clinical Data On BGB-3245, A Selective Next-Generation B-RAF Inhibitor, In Adult Patients With Advanced Or Refractory Solid Tumors At The American Association For Cancer Research Annual Meeting 2023

By Happy Mohamed

April 17, 2:31 PM

MapKure, LLC, BeiGene, Ltd. (NASDAQ:BGNE, HKEX: 06160, SSE: 688235)))), and SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), today announced that they will present updated clinical data from the Phase 1a/1b study of

BGNE

3 minute read

Vincerx Pharma Presents Preclinical Data On Novel Small Molecule Drug Conjugates At The American Association For Cancer Research Annual Meeting 2023

By Happy Mohamed

April 17, 1:37 PM

Vincerx Pharma, Inc. (NASDAQ:VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today presented a poster of preclinical

VINC

3 minute read

Caribou Biosciences Presents New Preclinical Data On CB-012, An Allogeneic Anti-CLL-1 CAR-T Cell Therapy, At The 2023 AACR Annual Meeting

By Happy Mohamed

April 17, 1:31 PM

-- CB-012 genome-edited armoring strategy significantly reduced tumor burden and improved overall survival in AML xenograft models -- -- CB-012 IND-enabling studies ongoing; IND submission in r/r AML planned for

CRBU

3 minute read

Harpoon Therapeutics Presents Data For New ProTriTAC Development Candidates In TROP2- And ITGB6-Expressing Solid Tumors At AACR 2023

By Happy Mohamed

April 17, 1:31 PM

Harpoon Therapeutics, Inc. (NASDAQ:HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today presented preclinical data on two new development candidates from the proprietary

HARP

2 minute read

EXCLUSIVE: 4 Experts Reveal How To Pinpoint A Cannabis Buyer Persona

By Jelena Martinovic

April 17, 11:34 AM

The ideal way to identify how and why consumers buy cannabis is through market research, several marketing experts said during a panel discussion hosted by Progress Partners EIR Director Jessica Straw at the 2023 Benzinga Can

CSE:TRUL